Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Tao ^a   Wang, Jing ^a   Li, Chenhui ^a   Zhang, Weining ^b   Zhang, Luyong ^a   An, Lufan ^c   Pang, Tao ^a   Shi, Xinzhong ^a   Liao, Hong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c Jiangsu Meitong Pharmaceutical Co LTD   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; GUANIDINE DERIVATIVE; NAFAMSTAT; NEUROPROTECTIVE AGENT; PLASMIN; THROMBIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN ISCHEMIA; DOSE RESPONSE; DRUG EFFECTS; MALE; METABOLISM; NERVE CELL; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTITHROMBINS; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYSIN; GUANIDINES; MALE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; THROMBIN; TREATMENT OUTCOME;

EID: 84903792690     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05531     Document Type: Article

References (44)

1. Latour, L. L., Kang, D. W., Ezzeddine, M. A., Chalela, J. A. & Warach, S. Early blood-brain barrier disruption in human focal brain ischemia. Ann. Neurol. 56, 468-477 (2004). (Pubitemid 39319336)
2. Chen, B., Cheng, Q., Yang, K. & Lyden, P. D. Thrombin mediates severe neurovascular injury during ischemia. Stroke 41, 2348-2352 (2010).
3. Xi, G., Keep, R. F., Hua, Y., Xiang, J. & Hoff, J. T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30, 1247-1255 (1999). (Pubitemid 29259182)
4. Lee, K. R., Kawai, N., Kim, S., Sagher, O. & Hoff, J. T. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J. Neurosurg. 86, 272-278 (1997). (Pubitemid 27130687)
5. Brummel, K. E., Paradis, S. G., Butenas, S. & Mann, K. G. Thrombin functions during tissue factor-induced blood coagulation. Blood 100, 148-152 (2002). (Pubitemid 35177440)
6. Nesheim, M. et al. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb. Haemostasis. 78, 386-391 (1997). (Pubitemid 27289272)
7. Schoenmakers, S. H., Reitsma, P. H. & Spek, C. A. Blood coagulation factors as inflammatory mediators. Blood Cell Mol. Dis. 34, 30-37 (2005). (Pubitemid 40017977)
8. Xi, G., Reiser, G. & Keep, R. F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J. Neurochem. 84, 3-9 (2003). (Pubitemid 36182060)
9. Chen, B. et al. Thrombin activity associated with neuronal damage during acute focal ischemia. J. Neurosci. 32, 7622-7631 (2012).
10. Hua, Y., Wu, J., Keep, R., Hoff, J. & Xi, G. in Brain Edema XII 163-166 (Springer, 2003).
11. Shikamoto, Y. & Morita, T. Expression of factor X in both the rat brain and cells of the central nervous system. FEBS Lett. 463, 387-389 (1999). (Pubitemid 30001956)
12. de Castro Ribeiro, M. et al. Thrombin in ischemic neuronal death. Exp. Neurol. 198, 199-203 (2006). (Pubitemid 43243757)
13. Okajima, K., Uchiba, M. & Murakami, K. Nafamostat mesilate. Cardiovasc. Drug Rev. 13, 51-65 (1995).
14. Hitomi, Y., Ikari, N. & Fujii, S. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Pathophysiol. Haemo. T. 15, 164-168 (1985). (Pubitemid 15037264)
15. Uchiba, M., Okajima, K., Abe, H., Okabe, H. & Takatsuki, K. Effect of nafamostat mesilate, a synthetic protease inhibitor, on tissue factor-factor VIIa complex activity. Thromb. Res. 74, 155-161 (1994).
16. Vivien, D. & Buisson, A. Serine protease inhibitors: novel therapeutic targets for stroke? J. Cereb. Blood Flow Metab. 20, 755-764 (2000). (Pubitemid 30317049)
17. Wang, J., Jin, H., Hua, Y., Keep, R. F. & Xi, G. Role of protease-activated receptor-1 in brain injury after experimental global cerebral ischemia. Stroke 43, 2476-2482 (2012).
18. Cuomo, O. et al. Antithrombin reduces ischemic volume, ameliorates neurologic deficits, and prolongs animal survival in both transient and permanent focal ischemia. Stroke 38, 3272-3279 (2007). (Pubitemid 350175748)
19. Dihanich, M., Kaser, M., Reinhard, E., Cunningham, D. & Monard, D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581 (1991).
20. Riek-Burchardt, M., Striggow, F., Henrich-Noack, P., Reiser, G. & Reymann, K. Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci. Lett. 329, 181-184 (2002). (Pubitemid 34880068)
21. Sanchez, A. et al. Neurovascular unit and the effects of dosage in VEGF toxicity: role for oxidative stress and thrombin. J. Alzheimers Dis. 34, 281-291 (2013).
22. Hua, Y., Keep, R. F., Gu, Y. & Xi, G. Thrombin and brain recovery after intracerebral hemorrhage. Stroke 40, S88-89 (2009).
23. Tripathy, D. et al. Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia. Front. Aging Neurosci. 5, 19 (2013).
24. Macfarlane, S. R., Seatter, M. J., Kanke, T., Hunter, G. D. & Plevin, R. Proteinaseactivated receptors. Pharmacol. Rev. 53, 245-282 (2001).
25. Coughlin, S. R. Thrombin signalling and protease-activated receptors. Nature 407, 258-264 (2000).
26. Sokolova, E. & Reiser, G. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: Localization, expression and participation in neurodegenerative diseases. Thromb. Haemostasis. 100, 576-581 (2008).
27. Wang, H. & Reiser, G. Thrombin signaling in the brain: the role of proteaseactivated receptors. Biol. Chem. 384, 193-202 (2003). (Pubitemid 36348318)
28. Rohatgi, T., Sedehizade, F., Reymann, K. G. & Reiser, G. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain. Neuroscientist 10, 501-512 (2004). (Pubitemid 39546393)
29. Luo, W., Wang, Y. & Reiser, G. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res. Rev. 56, 331-345 (2007). (Pubitemid 350176599)
30. Junge, C. E. et al. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 100, 13019-13024 (2003). (Pubitemid 37340018)
31. Turgeon, V. L., Lloyd, E. D., Wang, S., Festoff, B. W. & Houenou, L. J. Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J. Neurosci. 18, 6882-6891 (1998). (Pubitemid 28388018)
32. Donovan, F. M., Pike, C. J., Cotman, C. W. & Cunningham, D. D. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J. Neurosci. 17, 5316-5326 (1997). (Pubitemid 27300299)
33. Turgeon, V. L., Milligan, C. E. & Houenou, L. J. Activation of the proteaseactivated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J. Neuropath. Exp. Neur. 58, 499-504 (1999). (Pubitemid 29220743)
34. Almonte, A. G. & Sweatt, J. D. Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior. Brain Res. 1407, 107-122 (2011).
35. Mhatre, M. et al. Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol. Aging 25, 783-793 (2004). (Pubitemid 38698252)
36. Longa, E. Z., Weinstein, P. R., Carlson, S. & Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91 (1989). (Pubitemid 19040218)
37. Kawai, H., Yuki, S., Sugimoto, J. & Tamao, Y. Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 278, 780-785 (1996). (Pubitemid 27167046)
38. Lyden, P. et al. Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models. Stroke 45, 896-899 (2014).
39. Kilic, E., Özdemir, Y. G., Hayrunnisa Bolay, H. K. & scedil. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J. Cereb. Blood Flow Metab. 19, 511-516 (1999). (Pubitemid 30159813)
40. Tsubokawa, T. et al. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke 37, 1888-1894 (2006). (Pubitemid 44297747)
41. Galvão, R. P., Garcia-Verdugo, J. M. & Alvarez-Buylla, A. Brain-derived neurotrophic factor signaling does not stimulate subventricular zone neurogenesis in adult mice and rats. J. Neurosci. 28, 13368-13383 (2008).
42. Bushi, D. et al. Quantitative detection of thrombin activity in an ischemic stroke model. J. Mol. Neurosci. 51, 844-850 (2013).
43. Mu, J., Ostrowski, R. P., Krafft, P. R., Tang, J. & Zhang, J. H. Serum leptin levels decrease after permanent MCAo in the rat and remain unaffected by delayed hyperbaric oxygen therapy. Med. Gas Res. 3, 8 (2013).
44. Chan, C. B. et al. Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex. J. Neurosci. 31, 8083-8092 (2011).